MedtronicXSWX:MDT +1.21%21 14-Day RSI is 60.64 as of Jun. 25, 2026. GuruFocus rates XSWX:MDT with a GF Score™ of 21/100 and a GF Value™ of CHF80.97 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 871 Medical Devices & Instruments companies, Medtronic ranks worse than 82.32% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-06-25), Medtronic's 14-Day RSI is 60.64.
The industry rank for Medtronic's 14-Day RSI or its related term are showing as below:
XSWX:MDT's 14-Day RSI is ranked worse than 82.32% of 871
companies
in the Medical Devices & Instruments industry
Industry Median: 43.62
vs XSWX:MDT: 60.64
Medtronic (XSWX:MDT) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Medtronic 14-Day RSI Related Terms
XSWX:MDT vs SYK, BSX, EW: 14-Day RSI Comparison
For the Medical Devices subindustry, Medtronic's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medtronic 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Medtronic's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medtronic (XSWX:MDT) has a 14-Day RSI of 60.64 as of Jun. 25, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Medtronic and its competitors. According to the industry distribution chart, Medtronic ranks #717 out of 871 companies in the Medical Devices & Instruments industry, placing it in the top 82.3%.
Is Medtronic's 14-Day RSI too high?
Medtronic's current 14-Day RSI is 60.64. The Medical Devices & Instruments industry median 14-Day RSI is 43.62. Medtronic's value of 60.64 is 39% above this industry median. Based on the distribution chart, Medtronic ranks #717 out of 871 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medtronic has a GF Score™ of 21/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's 14-Day RSI compare to SYK and BSX?
According to the Medical Devices & Instruments industry distribution chart, Medtronic ranks #717 out of 871 companies for 14-Day RSI. This places Medtronic in the lower half of its industry. The industry median 14-Day RSI is 43.62. Medtronic's value of 60.64 is 39% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 43.62, based on 871 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medtronic's current 14-Day RSI of 60.64 is 39% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Medtronic and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 43.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medtronic's current 14-Day RSI is 60.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (XSWX:MDT) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF80.97, compared to a current price of CHF65.29 — trading 19.4% below its estimated fair value. The current 14-Day RSI is 60.64 and 39% above the Medical Devices & Instruments industry median of 43.62. Medtronic's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Medtronic (XSWX:MDT), the current 14-Day RSI is 60.64 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medtronic (XSWX:MDT) Overvalued in 2026?
Based on GuruFocus' analysis, Medtronic stock appears to be undervalued.
The current stock price of CHF65.29 is trading 19.4% below its estimated GF Value™ of CHF80.97.
GuruFocus considers Medtronic to be Modestly Undervalued.
Key valuation signals for XSWX:MDT:
14-Day RSI: 60.64
GF Value™: CHF80.97 vs. price of CHF65.29 (19.4% below fair value)
Industry Position: 39% above the Medical Devices & Instruments median (#717 of 871)
No single metric tells the full story. See the XSWX:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
21GF Score
Get the complete analysis for XSWX:MDT
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MDT has been successfully added to your 